Understanding Primary Erythromelalgia
At a Glance
Primary erythromelalgia is a rare, chronic pain condition causing severe burning, redness, and warmth in the hands and feet. Often linked to an SCN9A gene mutation, flares are typically triggered by heat or exercise. Treatment focuses on reducing symptoms and improving quality of life.
Primary erythromelalgia is a rare and complex chronic pain condition that primarily affects the hands and feet [1][2]. Because it is so uncommon, many patients find that they must become their own best advocates while navigating a medical system that may not be familiar with their symptoms [3].
The name itself describes the condition’s physical appearance: erythema (redness), melos (extremities), and algia (pain) [2]. While the journey to a diagnosis can be frustrating and long, understanding the mechanics of the condition is the first step toward building an effective management plan.
The Classic Triad
Primary erythromelalgia is identified by a specific group of three symptoms, often referred to as the “classic triad” [4][5]:
- Redness (Erythema): The skin in the affected area, usually the feet or hands, turns a deep red or purple color during an episode [1][2].
- Warmth: The affected skin feels significantly hotter to the touch than other parts of the body [4].
- Burning Pain: The pain is often described as a severe, paroxysmal (sudden and recurring) burning sensation [1][6].
These symptoms are almost always bilateral, meaning they occur on both sides of the body (e.g., both feet) [2]. They are typically triggered or made worse by heat, physical exercise, or gravity (such as standing for long periods), and are often relieved by cooling and elevation [5][6]. Learn more about triggers in Identifying and Managing Symptoms.
Why It Happens: The Genetic Link
The “primary” in primary erythromelalgia means the condition is not caused by another underlying disease (like a blood disorder). Instead, it is often related to how the body’s nerves communicate pain [7].
In many cases, the condition is linked to a mutation in the SCN9A gene [8][1]. This gene provides instructions for making part of a sodium channel called NaV1.7, which acts like a “volume knob” for pain signals in your nerves [9][10]. In primary erythromelalgia, this knob is stuck in the “on” position (a gain-of-function mutation), causing the nerves to fire pain signals even when there is no injury [11][10].
It is important to note:
- Not everyone has the mutation: While SCN9A is a known cause, researchers only find this specific mutation in a small proportion of people with the condition [8][12].
- Inheritance: The condition can be autosomal dominant, meaning it can be passed down from a single parent, but it can also appear “out of the blue” as a new mutation [4][7].
For more details on diagnosis, see Biology and Diagnosis: Finding the Cause.
The Diagnostic Journey
Because primary erythromelalgia is extremely rare—affecting roughly 1 to 2 people out of every 100,000—the road to diagnosis can be isolating [3]. Many patients see multiple specialists before finding someone who recognizes the symptoms.
Emotional and Physical Challenges
Living with chronic, severe pain is a heavy burden. It is normal to feel:
- Psychological Distress: The severity of the pain and its impact on daily life can lead to significant stress, anxiety, or feelings of hopelessness [13][14].
- Isolation: Because the condition is rare, you may feel like those around you—or even your doctors—don’t fully understand what you are going through.
A Note on Safety
During a flare, the urge to cool the skin is intense. However, experts caution against “improper cooling techniques,” such as plunging limbs into ice water for long periods [3]. This can lead to skin damage, ulcers, or infections. Always discuss safe cooling methods with a specialist.
Moving Forward
While primary erythromelalgia is a chronic condition, it is manageable. Current medical consensus favors a multidisciplinary approach, which may include a combination of specialized medications, lifestyle adjustments to avoid triggers, and psychological support to manage the impact of chronic pain [15][16][17].
It is important to set realistic expectations: a complete cure or a “zero-pain state” is highly unlikely for most patients. Instead, the clinical goal is “meaningful symptom reduction” [18][19]. Finding a care team—often including a neurologist and a dermatologist—who understands rare neuropathies is a crucial step in improving your quality of life [11]. Learn how to build your care team in Building Your Care Team and Treatment Strategy.
In this guide
3 chapters
Identifying and Managing Symptoms
Learn how to manage primary erythromelalgia (PEM) symptoms. Discover common flare triggers like heat and exercise, and know when to seek medical help.
Biology and Diagnosis: Finding the Cause
Learn about the biology and diagnosis of primary erythromelalgia (PEM). Understand the SCN9A gene, the difference between primary and secondary, and key tests.
Building Your Care Team and Treatment Strategy
Explore primary erythromelalgia (PEM) treatment options. Learn how to build your care team, evaluate sodium channel blockers, and safely manage pain flares.
Common questions in this guide
What are the main symptoms of primary erythromelalgia?
What triggers a primary erythromelalgia flare?
Is primary erythromelalgia genetic?
How can I safely cool my skin during a flare?
Is there a cure for primary erythromelalgia?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What is my diagnostic code (ICD-10), and is it for primary or secondary erythromelalgia?
- 2.Can you check my medical history for potential triggers or underlying conditions that might mimic erythromelalgia?
- 3.Should I undergo genetic testing for the SCN9A mutation, and what would the results mean for my treatment and my family?
- 4.What is your experience in treating rare pain disorders like this, or can you refer me to a specialist (like a neurologist or dermatologist) who has this expertise?
- 5.What are the safest ways for me to cool my feet during a flare without damaging my skin?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (19)
- 1
Erythromelalgia: A Child With V400M Mutation in the SCN9A Gene.
Nwebube C, Bulancea S, Marchidann A, et al.
Neurology. Genetics 2021; (7(2)):e570 doi:10.1212/NXG.0000000000000570.
PMID: 33688580 - 2
Eltrombopag-associated erythromelalgia in idiopathic thrombocytopenic purpura.
Perez J, Khouri C, Park S, et al.
The British journal of dermatology 2022; (186(3)):585-586 doi:10.1111/bjd.20829.
PMID: 34698373 - 3
Severe Erythromelalgia Pain Attack in a Young Lebanese Woman Leading to Hospitalization: A Case Report and Literature Review.
Assaad W, El Tarras O, Al Osta S, Kallassy C
Cureus 2025; (17(9)):e91530 doi:10.7759/cureus.91530.
PMID: 41050026 - 4
Reduction in pain following treatment with ranolazine in primary erythromelalgia: a case report.
Greco C, Chaumon S, Viallard ML, Bodemer C
The British journal of dermatology 2018; (179(3)):783-784 doi:10.1111/bjd.16654.
PMID: 29624653 - 5
Clinical features and management of erythromelalgia: long term follow-up of 46 cases.
Parker LK, Ponte C, Howell KJ, et al.
Clinical and experimental rheumatology 2017; (35(1)):80-84.
PMID: 27494156 - 6
Secondary erythromelalgia: a tryptophan dietary supplement-induced case associated with elevated 5-hydroxyindoleacetic acid (5HIAA) urinary levels.
Michelerio A, Derlino F, Brazzelli V, Vassallo C
International journal of dermatology 2018; (57(1)):83-85 doi:10.1111/ijd.13760.
PMID: 29152720 - 7
Review of primary and secondary erythromelalgia.
Mann N, King T, Murphy R
Clinical and experimental dermatology 2019; (44(5)):477-482 doi:10.1111/ced.13891.
PMID: 30609105 - 8
Genetic Variants in the SCN9A Gene are Detected in a Minority of Erythromelalgia Patients.
Skystad Kvernebo M, Grayson C, Stylianou IM, et al.
Acta dermato-venereologica 2025; (105()):adv42022 doi:10.2340/actadv.v105.42022.
PMID: 39850993 - 9
A severe case of primary erythromelalgia presenting as small fiber neuropathy with a novel SCN9A mutation.
Watabe D, Tominaga M, Toyama S, et al.
The Journal of dermatology 2023; (50(7)):938-941 doi:10.1111/1346-8138.16754.
PMID: 36815391 - 10
Insensitivity to Pain upon Adult-Onset Deletion of Nav1.7 or Its Blockade with Selective Inhibitors.
Shields SD, Deng L, Reese RM, et al.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2018; (38(47)):10180-10201 doi:10.1523/JNEUROSCI.1049-18.2018.
PMID: 30301756 - 11
Pediatric Erythromelalgia and SCN9A Mutations: Systematic Review and Single-Center Case Series.
Arthur L, Keen K, Verriotis M, et al.
The Journal of pediatrics 2019; (206()):217-224.e9 doi:10.1016/j.jpeds.2018.10.024.
PMID: 30416015 - 12
Painful, reappearing eruption in a medically complex 4-year-old.
Sooy M, Randell RL, Tchapyjnikov D, et al.
BMJ case reports 2021; (14(2)) doi:10.1136/bcr-2020-239310.
PMID: 33602765 - 13
Severe Pediatric Erythromelalgia: A Case Report on Multimodal Pain Management and the Role of Regional Anesthesia.
Zyani A, El Moutawakil El Alami M, Alkouh R, et al.
Cureus 2024; (16(10)):e71351 doi:10.7759/cureus.71351.
PMID: 39534843 - 14
Efficacy and safety of acupuncture therapy for neuropsychiatric symptoms among patients with Parkinson's disease: A systematic review and meta-analysis.
Tan W, Xie F, Zhou J, et al.
Clinical rehabilitation 2024; (38(8)):1044-1062 doi:10.1177/02692155241258278.
PMID: 38840478 - 15
Procedural interventions for erythromelalgia: A narrative review.
Lee JU, Ma JE, Sartori Valinotti JC, et al.
Vascular medicine (London, England) 2024; (29(6)):723-732 doi:10.1177/1358863X241279427.
PMID: 39319570 - 16
[A clinical case of erythromelalgia in a patient comorbid with antiphospholipid syndrome].
Kudrjavtseva AA, Meladze AV, Trapeznikova ES, et al.
Terapevticheskii arkhiv 2026; (97(12)):1018-1022 doi:10.26442/00403660.2025.12.203468.
PMID: 41705614 - 17
Erythromelalgia: A Review of Medical Management Options and Our Approach to Management.
Ma JE, Lee JUJ, Sartori-Valinotti JC, et al.
Mayo Clinic proceedings 2023; (98(1)):136-149 doi:10.1016/j.mayocp.2022.08.005.
PMID: 36470753 - 18
[Erythromelalgia: Diagnosis and therapeutic approach].
Miranda S, Le Besnerais M, Langlois V, et al.
La Revue de medecine interne 2017; (38(3)):176-180 doi:10.1016/j.revmed.2016.08.012.
PMID: 27639908 - 19
Erythromelalgia successfully treated with low-dose gabapentin in a pediatric patient.
Phong CH, Birmingham SW, Rojek NW
SAGE open medical case reports 2022; (10()):2050313X221136768 doi:10.1177/2050313X221136768.
PMID: 36406307
This page provides educational information about primary erythromelalgia. It does not replace professional medical advice. Always consult your healthcare provider or specialist regarding your specific symptoms, diagnosis, and treatment plan.
Get notified when new evidence is published on Primary erythromelalgia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.